These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2671859)
1. [IgA and IgG antibodies to Chlamydia in IgA nephropathy as well as in mesangiocapillary and membranous glomerulonephritis]. Nagy J; Sarov I; Sámik J; Trinn C; Kun L; Burger T; Sarov B Orv Hetil; 1989 Jul; 130(29):1527-30. PubMed ID: 2671859 [TBL] [Abstract][Full Text] [Related]
2. [Antinuclear antibodies in IgA nephropathy, as well as mesangiocapillary and membranous glomerulonephritis]. Nagy J; Goshen E; Livne A; Sarov I; Shoenfeld Y Orv Hetil; 1991 Mar; 132(12):623-8. PubMed ID: 2011384 [TBL] [Abstract][Full Text] [Related]
3. Studies on circulating immune complexes. II: Circulating immune complexes in primary IgA nephropathy and membranoproliferative glomerulonephritis. Miura Y Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):193-200. PubMed ID: 2739118 [TBL] [Abstract][Full Text] [Related]
4. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase. Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711 [TBL] [Abstract][Full Text] [Related]
5. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis. Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363 [TBL] [Abstract][Full Text] [Related]
6. Humoral immune response in patients with IgA and IgM glomerulonephritis. Pasternack A; Mustonen J; Leinikki P Clin Exp Immunol; 1986 Jan; 63(1):228-33. PubMed ID: 3955883 [TBL] [Abstract][Full Text] [Related]
7. Increased concentration of serum IgA antibody to pneumococcal polysaccharides in patients with IgA nephropathy. Drew PA; Nieuwhof WN; Clarkson AR; Woodroffe AJ Clin Exp Immunol; 1987 Jan; 67(1):124-9. PubMed ID: 3497740 [TBL] [Abstract][Full Text] [Related]
8. In vitro solubilization of glomerular immune deposits after incubation with human IgG and IgA in membranous and IgA nephropathy. Cirami C; Finato V; Andreini B; Bianchi AM; Panichi V; Montagnani E; Parrini M; Gattai V; Casarosa L; Palla R Clin Nephrol; 1993 Sep; 40(3):185. PubMed ID: 8403576 [No Abstract] [Full Text] [Related]
9. IgA-containing immune complexes in the urine of IgA nephropathy patients. Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497 [TBL] [Abstract][Full Text] [Related]
10. Mucosal immunity in primary glomerulonephritis: II. Study of the serum IgA subclass repertoire to food and airborne antigens. Rostoker G; Petit-Phar M; Delprato S; Terzidis H; Lang P; Dubert JM; Weil B; Lagrue G Nephron; 1991; 59(4):561-6. PubMed ID: 1766494 [TBL] [Abstract][Full Text] [Related]
11. Role of IgA, IgG, and IgM antibodies against Haemophilus parainfluenzae antigens in IgA nephropathy. Suzuki S; Gejyo F; Nakatomi Y; Odani S; Sato H; Arakawa M Clin Nephrol; 1996 Nov; 46(5):287-95. PubMed ID: 8953116 [TBL] [Abstract][Full Text] [Related]
12. Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions. Zhang JJ; Jiang L; Liu G; Wang SX; Zou WZ; Zhang H; Zhao MH Nephrology (Carlton); 2008 Dec; 13(8):712-20. PubMed ID: 18771467 [TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy. Schena FP; Pastore A; Ludovico N; Sinico RA; Benuzzi S; Montinaro V Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538 [TBL] [Abstract][Full Text] [Related]
14. Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases. Romano Carratelli C; Nuzzo I; Cozzolino D; Bentivoglio C; Paolillo R; Rizzo A Int Immunopharmacol; 2006 May; 6(5):848-53. PubMed ID: 16546716 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of immunoglobulins and complements in formaldehyde-fixed and paraffin-embedded renal biopsy tissues; an adjunct for diagnosis of glomerulonephritis. Chowdhury AR; Ehara T; Higuchi M; Hora K; Shigematsu H Nephrology (Carlton); 2005 Jun; 10(3):298-304. PubMed ID: 15958046 [TBL] [Abstract][Full Text] [Related]
16. Mucosal immunity in primary glomerulonephritis. III. Study of intestinal permeability. Rostoker G; Wirquin V; Terzidis H; Petit-Phar M; Chaumette MT; Delchier JC; Belghiti D; Lang P; Dubert JM; Meignan M Nephron; 1993; 63(3):286-90. PubMed ID: 8446265 [TBL] [Abstract][Full Text] [Related]
17. Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart disease. Schumacher A; Seljeflot I; Lerkerød AB; Sommervoll L; Otterstad JE; Arnesen H Eur J Clin Invest; 2005 Jul; 35(7):431-7. PubMed ID: 16008544 [TBL] [Abstract][Full Text] [Related]
18. Chlamydia pneumoniae seropositivity and risk of developing coronary heart disease in Western Saudi Arabia. Momenah AM; Tayeb MT Saudi Med J; 2005 Dec; 26(12):1926-9. PubMed ID: 16380774 [TBL] [Abstract][Full Text] [Related]
19. [Role of hepatitis B virus infection in chronic glomerulonephritis]. Kiperova B; Grouev I; Krastev Z; Naoumov N; Minkova V; Mateva L; Maleev A Ann Med Interne (Paris); 1989; 140(5):380-2. PubMed ID: 2688509 [TBL] [Abstract][Full Text] [Related]
20. In vivo alteration of antibody production in patients with IgA nephropathy. Endoh M; Suga T; Miura M; Tomino Y; Nomoto Y; Sakai H Clin Exp Immunol; 1984 Sep; 57(3):564-70. PubMed ID: 6380836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]